MDT

Medtronic
D

MDT

Arincen70/100B

Medtronic cash on hand 1986–2027

Medtronic had 8.82B USD in cash and short-term investments on 31 July 2026, up 8.6% on a year before. At the end of fiscal year 2026 it had 9.22B USD.

Last updated 6 Nov 2026 · Next report 24 Nov 2026

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter31 Jul 20268.82B+8.60%28.15B-19.33B
FY202624 Apr 20269.22B+2.84%27.96B-18.74B
FY202525 Apr 20258.97B+11.99%28.52B-19.55B
FY202426 Apr 20248.01B+0.58%25.02B-17.02B
FY202328 Apr 20237.96B-24.72%24.36B-16.41B
FY202229 Apr 202210.57B-2.26%24.11B-13.54B
FY202130 Apr 202110.82B-1.20%26.39B-15.57B
FY202030 Apr 202010.95B+11.17%24.80B-13.85B
FY201926 Apr 20199.85B-12.28%25.32B-15.47B
FY201827 Apr 201811.23B-18.10%25.76B-14.54B
FY201728 Apr 201713.71B+8.50%33.40B-19.69B
FY201629 Apr 201612.63B-35.14%31.01B-18.38B
FY201530 Apr 201519.48B+36.79%36.11B-16.63B
FY201425 Apr 201414.24B+28.63%11.87B2.37B
FY201330 Apr 201311.07B+327.12%10.62B456.00M
FY201230 Apr 20122.59B+6.75%10.47B-7.87B
FY201130 Apr 20112.43B-35.68%9.66B-7.23B
FY201030 Apr 20103.78B+125.24%9.52B-5.74B
FY200930 Apr 20091.68B+3.91%6.78B-5.10B
FY200830 Apr 20081.61B-47.60%6.96B-5.34B
FY200730 Apr 20073.08B-49.55%6.09B-3.01B
FY200630 Apr 20066.10B+79.90%7.92B-1.82B
FY200530 Apr 20053.39B+75.96%2.45B939.60M
FY200430 Apr 20041.93B+29.12%2.36B-431.80M
FY200330 Apr 20031.49B+179.71%2.37B-872.80M
FY200230 Apr 2002533.70M-56.67%2.53B-1.99B
FY200130 Apr 20011.23B+120.70%158.70M1.07B
FY200030 Apr 2000558.10M+151.28%332.10M226.00M
FY199930 Apr 1999222.10M-41.96%262.60M-40.50M
FY199830 Apr 1998382.70M+93.87%192.00M190.70M
FY199730 Apr 1997197.40M+78.97%120.40M77.00M
FY199630 Apr 1996110.30M+12.21%75.80M34.50M
FY199530 Apr 199598.30M-9.57%47.70M50.60M
FY199430 Apr 1994108.70M+41.17%78.40M30.30M
FY199330 Apr 199377.00M-23.61%102.80M-25.80M
FY199230 Apr 1992100.80M+13.51%89.20M11.60M
FY199130 Apr 199188.80M+145.30%98.80M-10.00M
FY199030 Apr 199036.20M-29.43%94.30M-58.10M
FY198930 Apr 198951.30M-34.65%79.90M-28.60M
FY198830 Apr 198878.50M-30.96%59.90M18.60M
FY198730 Apr 1987113.70M-16.03%37.40M76.30M
FY198630 Apr 1986135.40M—46.60M88.80M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about Medtronic's cash

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.